Class information for:
Level 1: CCDC134//TUMOR IMMUN TOLERANCE SECT//ANTIGEN SPECIFIC CTL FUNCTION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
23068 303 47.7 93%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
151 22214 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CCDC134 Author keyword 2 67% 1% 2
2 TUMOR IMMUN TOLERANCE SECT Address 1 30% 1% 3
3 ANTIGEN SPECIFIC CTL FUNCTION Author keyword 1 50% 0% 1
4 AUTOCHTHONOUS TUMORS Author keyword 1 50% 0% 1
5 CYTOKINE COMPLEXES Author keyword 1 50% 0% 1
6 DC T CELL INTERACTION Author keyword 1 50% 0% 1
7 GUSTAVE ROUSSY CURIE Address 1 50% 0% 1
8 IMMUNOTHER Y CANC INFECTIOUS DIS Address 1 50% 0% 1
9 LFGC Address 1 50% 0% 1
10 LYMPHOTOXIN A Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 CCDC134 2 67% 1% 2 Search CCDC134 Search CCDC134
2 ANTIGEN SPECIFIC CTL FUNCTION 1 50% 0% 1 Search ANTIGEN+SPECIFIC+CTL+FUNCTION Search ANTIGEN+SPECIFIC+CTL+FUNCTION
3 AUTOCHTHONOUS TUMORS 1 50% 0% 1 Search AUTOCHTHONOUS+TUMORS Search AUTOCHTHONOUS+TUMORS
4 CYTOKINE COMPLEXES 1 50% 0% 1 Search CYTOKINE+COMPLEXES Search CYTOKINE+COMPLEXES
5 DC T CELL INTERACTION 1 50% 0% 1 Search DC+T+CELL+INTERACTION Search DC+T+CELL+INTERACTION
6 LYMPHOTOXIN A 1 50% 0% 1 Search LYMPHOTOXIN+A Search LYMPHOTOXIN+A
7 MYOCARDIAL ISCHEMIA DETECTION 1 50% 0% 1 Search MYOCARDIAL+ISCHEMIA++DETECTION Search MYOCARDIAL+ISCHEMIA++DETECTION
8 PANCREATIC BETA CELL TUMOR 1 50% 0% 1 Search PANCREATIC+BETA+CELL+TUMOR Search PANCREATIC+BETA+CELL+TUMOR
9 REJECTION ANTIGEN 1 50% 0% 1 Search REJECTION+ANTIGEN Search REJECTION+ANTIGEN
10 SV40 T ANTIGEN TRANSGENIC MICE 1 50% 0% 1 Search SV40+T+ANTIGEN+TRANSGENIC+MICE Search SV40+T+ANTIGEN+TRANSGENIC+MICE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IN VIVO TOLERANCE 6 100% 1% 4
2 RESTRICTED CROSS PRESENTATION 4 28% 4% 13
3 IMMUNOLOGICAL IGNORANCE 3 31% 3% 8
4 PERIPHERALLY EXPRESSED ANTIGENS 3 42% 2% 5
5 ANTIGENIC CANCER CELLS 2 33% 2% 5
6 CHOROID PLEXUS TUMORS 2 16% 3% 10
7 ANTIGEN TRANSGENIC MICE 2 16% 3% 9
8 ALLOGENEIC TUMOR 1 100% 1% 2
9 TRANSFORMED MESENCHYMAL CELLS 1 100% 1% 2
10 RECOGNITION EPITOPES 1 30% 1% 3

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The role of tumor stroma in the interaction between tumor and immune system 2005 114 53 30%
Overcoming tumor-intrinsic resistance to immune effector function 2004 42 55 40%
The adaptive immune response to sporadic cancer 2007 37 76 18%
Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction 2009 4 37 49%
The role of stroma in immune recognition and destruction of well-established solid tumors 2006 66 64 17%
Do autochthonous tumors interfere with effector T cell responses? 2007 11 55 31%
Immunotherapy: target the stroma to hit the tumor 2005 48 64 28%
Does the immune system see tumors as foreign or self? 2003 419 159 9%
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response 2013 6 51 16%
Targeting the Stroma by T Cells to Limit Tumor Growth 2008 13 18 28%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 TUMOR IMMUN TOLERANCE SECT 1 30% 1.0% 3
2 GUSTAVE ROUSSY CURIE 1 50% 0.3% 1
3 IMMUNOTHER Y CANC INFECTIOUS DIS 1 50% 0.3% 1
4 LFGC 1 50% 0.3% 1
5 MERCK SERONO RD 1 50% 0.3% 1
6 SHEILA DAVID FUENTES PROGRAM CANC BIOL 1 50% 0.3% 1
7 UNITE RECH GENET PATHOL MOL 1 50% 0.3% 1
8 PATHOIMMUNOL 1 29% 0.7% 2
9 CIGTP 0 33% 0.3% 1
10 COMPREHENS CANC CHARITE 0 33% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000175965 CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//CHIMERIC IMMUNE RECEPTOR
2 0.0000171689 SECRETION INHIBITION//RNF13//PROTEASE ASSOCIATED DOMAIN
3 0.0000164168 FOXP3//TUMOR INFILTRATING LYMPHOCYTES//INTEGRAT CANC IMMUNOL
4 0.0000148358 CANC VACCINE DEV PROGRAM//CANC SECT//ONCOANTIGENS
5 0.0000145759 INTERDISCIPLINARY PROGRAM IMMUNOL//INTEGRATED IMMUNOL VACCINE//T CELL COMPETITION
6 0.0000137454 RECOMBINANT VACCINE GRP//ABSCOPAL EFFECT//IMMUNOGENIC TUMOR CELL DEATH
7 0.0000133867 CANCER TESTIS ANTIGEN//CANCER TESTIS ANTIGENS//NY ESO 1
8 0.0000123600 CROSS PRESENTATION//CHRIS BROWNE IMMUNOL IMMUNE DIS//CD207
9 0.0000118998 ANTIANGIOGENIC CANCER VACCINE//CELL PROTEOMIC FOOTPRINTING//HER1 VACCINE
10 0.0000115958 CD3 ZETA//ORAL BIOL ORAL MED//ZETA CHAIN